Szisztémás szklerózis (szkleroderma): vizsgálatok itt: Egyesült Államok

In Egyesült Államok 53 Also abroad 213

53 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

1/2. fázisTaking people
A Study of AZD0120 in Autoimmune Diseases
Where
Ann Arbor, Baltimore, Chapel Hill, Chicago, Duarte, Miami, New York, Seattle, Stanford, St Louis, Tucson
Életkor
18 év to 75 év
People
27 worldwide
Run by
AstraZeneca
See details and how to joinNCT07295847
3. fázisTaking people
Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
Where
Ann Arbor, Baltimore, Boca Raton, Boston, Charleston, Charlotte, Chicago, Cleveland, Columbus, Dallas, Fort Lauderdale, Indianapolis, Irvine, Los Angeles, New York, Omaha, Phoenix, Portland, Roanoke, Rochester, San Francisco
Életkor
5 év to 80 év
People
1072 worldwide
Run by
AstraZeneca
See details and how to joinNCT07691970
2. fázisNot yet taking people in Egyesült Államok
FAPI PET in Systemic Sclerosis Interstitial Lung Disease
Where
Los Angeles
Életkor
18 év and over
People
120
Run by
University of California, Los Angeles
See details and how to joinNCT07925242
2. fázisNot yet taking people in Egyesült Államok
Hyaluronidase Injections for Sclerodactyly in Patients With Scleroderma
Where
Stanford
Életkor
18 év and over
People
10
Run by
Stanford University
See details and how to joinNCT07916324
No phaseTaking people
Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images
Where
New Haven
Életkor
18 év and over
People
56
Run by
Yale University
See details and how to joinNCT07228429
1/2. fázisTaking people
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Where
Houston
Életkor
18 év and over
People
47
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT06434363
1. fázisTaking people
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Where
Aurora, Baltimore, Charleston, Charlotte, Chicago, Durham, East Brunswick, Greenville, Iowa City, Jacksonville, Kansas City, Loma Linda, Louisville, New York, Phoenix, Salt Lake City, Valhalla
Életkor
18 év to 74 év
People
66 worldwide
Run by
Allogene Therapeutics
See details and how to joinNCT07085104
1/2. fázisTaking people
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Where
Ann Arbor, Charlotte, Dallas, Fairway, Hackensack, Los Angeles, Minneapolis, New York, Plantation, Summit, Syracuse, Tampa
Életkor
18 év to 75 év
People
240
Run by
Nkarta, Inc.
See details and how to joinNCT06733935
No phaseTaking people
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Where
Sioux Falls
People
20 000
Run by
Sanford Health
See details and how to joinNCT01793168
1. fázisTaking people
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
Where
Boston, Chapel Hill, Chicago, Iowa City, La Jolla, New Orleans, Portland, Redwood City, St Louis
Életkor
18 év to 70 év
People
80 worldwide
Run by
CRISPR Therapeutics
See details and how to joinNCT06925542
No phaseTaking people
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
Where
New York
Életkor
18 év and over
People
2000
Run by
Weill Medical College of Cornell University
See details and how to joinNCT01776398
2/3. fázisTaking people
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Where
Ann Arbor, Chicago, Durham, Jacksonville, Kansas City, New Haven, New York, Rochester
Életkor
18 év to 75 év
People
37
Run by
Cabaletta Bio
See details and how to joinNCT06328777
Korai 1. fázisNot yet taking people in Egyesült Államok
Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial
Where
Charleston
Életkor
18 év to 60 év
People
10
Run by
Medical University of South Carolina
See details and how to joinNCT07697274
3. fázisTaking people
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Where
Ann Arbor, Aurora, Austin, Baltimore, Birmingham, Boston, Chicago, Frisco, Houston, Jackson, Los Angeles, Minneapolis, New Brunswick, New Orleans, New York, Ormond Beach, Philadelphia, Phoenix, Plantation, Saint Clair Shores, San Diego, Scottsdale, South Miami, Stanford, Washington D.C., Whittier
Életkor
18 év and over
People
448 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00
1. fázisNot yet taking people in Egyesült Államok
A Study of BMS-986553 in Participants With Refractory Autoimmune Diseases
Where
Ann Arbor, Great Neck, Morristown, Newport Beach, Omaha, Philadelphia, Saint Paul, Salt Lake City, Seattle, Worcester
Életkor
18 év and over
People
60 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07873931
1. fázisNot yet taking people in Egyesült Államok
C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell Therapy, in Participants With Systemic Sclerosis (SSc) Refractory to Standard Therapy
Where
Gilbert
Életkor
18 év to 70 év
People
12
Run by
AbelZeta Inc.
See details and how to joinNCT07854483
1. fázisTaking people
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Where
Atlanta, Baltimore, Bethesda, Birmingham, Boston, Chicago, City of Saint Peters, Columbus, Creve Coeur, Dallas, Detroit, Fairway, Fort Worth, Hays, Houston, Kansas City, Lawrence, Lee's Summit, Lexington, Mineola, New Brunswick, New Haven, New York, North Kansas City, Olathe, Overland Park, Palo Alto, Philadelphia, Pittsburg, Pittsburgh, Richardson, Richmond, Sacramento, Salina, Salt Lake City, St Louis, Topeka, Washington D.C., Westwood
Életkor
18 év and over
People
300 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT03816345
2. fázisTaking people
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Where
Allen, Aurora, Baltimore, Boston, Brooklyn, Clearwater, Cleveland, Dallas, Houston, Kansas City, La Jolla, Loma Linda, Los Angeles, Minneapolis, Newport Beach, Oklahoma City, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Sarasota, Tampa
Életkor
18 év and over
People
85 worldwide
Run by
Mediar Therapeutics
See details and how to joinNCT07287670
No phaseCsak meghívásos
Comparative Autoantibody and Immunologic Cell Marker Study
Where
Atlanta
Életkor
18 év and over
People
2500
Run by
Emory University
See details and how to joinNCT02422875
2. fázisTaking people
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Where
Baltimore, New Orleans
Életkor
18 év and over
People
30
Run by
Johns Hopkins University
See details and how to joinNCT04797286
1. fázisCsak meghívásos
A Study of KITE-363 in Participants With Refractory Autoimmune Diseases
Where
Duarte, New York, Stanford, Tampa
Életkor
18 év and over
People
52 worldwide
Run by
Kite, A Gilead Company
See details and how to joinNCT07038447
No phaseTaking people
Hormonal, Metabolic, and Signaling Interactions in PAH
Where
Nashville
Életkor
Up to 90 év
People
1899
Run by
Vanderbilt University Medical Center
See details and how to joinNCT01884051
3. fázisNot yet taking people in Egyesült Államok
A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis
Where
Ann Arbor, Atlanta, Aurora, Charleston, Chicago, Cleveland, Dallas, Denver, Houston, Miami, Philadelphia, Pittsburgh, Rochester, Scottsdale, Seattle, Summit, Worcester
Életkor
16 év and over
People
92 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07335562 · EU 2025-524337-11-00
3. fázisTaking people
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Where
Los Angeles, New York, Philadelphia
Életkor
18 év and over
People
514 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06716606
2/3. fázisTaking people
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Where
Ann Arbor, Aurora, Baltimore, Chicago, Cincinnati, Denison, El Paso, Houston, Jacksonville, Los Angeles, Miami, New Brunswick, New York, Philadelphia, Phoenix, Pittsburgh, Potsdam, Scottsdale, Tucson, Upland, Washington D.C.
Életkor
18 év and over
People
300 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT05878717 · EU 2023-503219-14-01